Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of MK‐2060 after intravenous (IV) administration of single and multiple doses in older adult participants with end‐stage renal disease (ESRD) on hemodialysis (HD).
Epistemonikos ID: 5bf31ee3b36f5d8eb695d1a5dda8e5e069015167
First added on: Oct 03, 2023